Pfizer's Hematology portfolio continues to grow and is expected to bring significant value to the patients whom we are here to serve and to our Hematology/Oncology Business at Pfizer. The Hematology/Oncology portfolio is focused on Leukemia core brands (BOSULIF and BESPONSA) and is headed to expand including Multiple Myeloma (MM) and Non Hodgkin's Lymphoma (NHL), with key novel targets like BCMA bispecific (elranatamab) and CD47 blocking agents (TTI-621 and TTI-622), that support our entry into lymphoid malignancies space.
Reporting to the Vice President, Global Franchise Lead Hematology and Biosimilars, the Global Hematology Senior Medical Director Lymphoma is accountable for the development and execution of global medical affairs strategy in Lymphoma, including evidence generation, communication, and global external engagement. The Global Hematology Senior Medical Director -Lymphoma will partner cross-functionally with medical teams, health and value functions, clinical development, legal, compliance and commercial teams to execute activities. The Global Hematology Senior Medical Director -Lymphoma will collaborate directly with country medical teams to understand major unmet medical needs and the HCP and patient perspective, regulatory and access dynamics at the country level and integrate needs and insights to co-create a global medical plan.ROLE RESPONSIBILITIES
The Global Hematology Senior Medical Director -Lymphoma will:
- Facilitate scientific engagement across a broad range of stakeholders to strengthen external understanding of the unmet need in Lymphoma
- Be member of the CD47 Global Medicine Team, working with GPD, Commercial, PHI, Regulatory, Policy.
- Develop strategic evidence generation and dissemination plans
- Lead or support the execution of evidence generation activities including independent research, clinical and research collaborations, and Pfizer non-interventional and interventional studies including post-hoc data generation
- Lead internal data interpretation and alignment activities
- Lead evidence dissemination and education activities including scientific publications and scientific exchange
Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.
- MD plus accredited fellowship in Hematology-Oncology, board certified or board eligible
- Substantial understanding/expertise of relevant therapeutic area (Lymphoma) required.
- Proven leadership skills in a cross-functional global team environment
- Strong clinical and disease knowledge in Lymphoma and other hematological malignancies
- 5+ years experience in Medical Affairs required
- Cross functional effectiveness
- Leading effectively in a matrix
- Proven track record of ability to work successfully with cross-functional colleagues in a matrix team setting across countries and internationally with diverse colleagues
- Very strong communications and relationship building capacity and ability to listen, understand and integrate country and local needs
- Fluency in written and spoken English required
Other Job Details:
- Launch experience a plus
- Global experience a plus
- Regulatory and/or clinical development experience a plus
Last Date to Apply for Job: December 18th, 2022
Additional Location Information: New York, NY; Collegeville, PA; Cambridge, MA; Peapack, NJ; Europe - Any Pfizer site
Eligible for Relocation Package: No
For roles based in New York City: The annual base salary for this position ranges from $236,900.00 to $394,800.00. In addition, this position offers an annual bonus with a target of 25.0% of the base salary and eligibility to participate in our share based long term incentive program. Benefits offered include a retirement savings plan, paid vacation, holiday and personal days, paid caregiver/parental and medical leave, and health benefits to include medical, prescription drug, dental and vision coverage in accordance with the terms and conditions of the applicable plans.
Relocation assistance may be available based on business needs and/or eligibility.Pfizer requires all U.S. new hires to be fully vaccinated for COVID-19 prior to the first date of employment. As required by applicable law, Pfizer will consider requests for Reasonable Accommodations.Sunshine Act
Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider's name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative. EEO & Employment Eligibility
Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer.